Pharma Export License India to Africa: Step-by-Step
Categories
Tags
You May Also Like
Introduction
Before a single carton of medicine ships to Lagos, Nairobi, or Accra, an Indian exporter needs a specific stack of licenses in place at home — separate from whatever registration the destination country requires. Getting a pharma export license India to Africa deals with isn’t one document, but a layered set of approvals from DGFT, the state drug authority, and CDSCO, each serving a different regulatory purpose.
This guide walks through exactly what’s needed on the Indian side, step by step, before a product is even ready to begin NAFDAC, PPB, or FDA Ghana registration on the African side.
Why This Is a Layered Process, Not One License
Unlike many product categories, pharmaceuticals require export approval at two separate levels in India: a general trade-level authorization that applies to any exported goods, and a pharma-specific regulatory layer governed by the Drugs and Cosmetics Act.
Key reasons the process has multiple layers: An IEC (Importer Exporter Code) is a general business requirement for any Indian company engaged in import or export, and is not specific to pharmaceuticals. A drug export licence, issued under the Drugs and Cosmetics Act by CDSCO or the State Drug Controller, is specific to pharmaceutical products and required in addition to the IEC.
- Certain products or destination countries may trigger additional CDSCO-specific approval requirements beyond the base export license
- Each license serves customs, quality-control, and international-compliance purposes independently
Licenses and Registrations Required
1. Import Export Code (IEC)
Issued by the Directorate General of Foreign Trade (DGFT), this is mandatory for all exports regardless of product category — the foundational registration needed before any export business can legally operate.
2. Drug Manufacturing / Wholesale License
Issued under the Drugs and Cosmetics Act, 1940, this confirms the exporting entity is authorized to manufacture or deal in pharmaceutical products domestically — a prerequisite for pharma-specific export activity.
3. Drug Export NOC (No Objection Certificate)
Granted by CDSCO or the State Licensing Authority, this NOC allows Indian manufacturers to legally export pharmaceutical products abroad, covering approved, unapproved, and banned drug categories depending on the case. Manufacturers must hold a valid license under Form 25 or 28 and comply with quality control standards to apply, with the application requiring an export order, covering letter, purchase order, manufacturing license, and invoice.
4. Certificate of Pharmaceutical Product (COPP)
Exporters must obtain a COPP issued by CDSCO for each pharmaceutical product intended for export, certifying that the product is manufactured in compliance with Indian regulatory standards.</cite> This is the document African regulators (NAFDAC, PPB, FDA Ghana) will require as part of their own product registration process.
5. Free Sale Certificate (FSC)
Exporters may also be required to provide an FSC issued by CDSCO, attesting to the product’s free-sale status in India.
6. GMP Certification
This ensures manufacturing follows WHO Good Manufacturing Practices — increasingly a baseline expectation from African buyers and regulators alike, not just a nice-to-have.
7. GST Registration
Required for export compliance, with exports treated as zero-rated under GST.
Step-by-Step Process
Step 1: Register for an IEC Apply through DGFT — this is the starting point for any export activity and typically the fastest of the required registrations.
Step 2: Confirm Your Manufacturing/Wholesale Drug License Is Current This should already be in place for any operating pharmaceutical manufacturer, but confirm it covers the specific product categories you intend to export.
Step 3: Apply for the Drug Export NOC Submit the export order, manufacturing license, invoice, and supporting documents to CDSCO or your State Licensing Authority.
Step 4: Obtain COPP and FSC for Each Product These are issued per product, not per company — budget time for this on a product-by-product basis as you expand your export catalog.
Step 5: Confirm GMP Certification Status Ensure your manufacturing site’s WHO-GMP certification is current, since this underpins COPP issuance and is frequently required directly by African regulators too.
Step 6: Proceed to Destination-Country Registration With IEC, drug license, NOC, COPP, and FSC in place, you’re positioned to begin the separate registration process with NAFDAC, PPB, or FDA Ghana for your target African market.
Common Mistakes That Delay the Process
Treating the IEC as Sufficient on Its Own The IEC gets you export-eligible as a business, but pharmaceutical products still need the drug-specific NOC, COPP, and FSC layered on top.
Applying for COPP/FSC Too Late Since African regulators require these as part of their own registration dossiers, delays here cascade directly into delays on the NAFDAC, PPB, or FDA Ghana side.
Inconsistent Documentation Across Licenses Product names, manufacturing site details, and specifications should match exactly across the IEC, drug license, NOC, and COPP to avoid queries at any stage.
Assuming One-Time Approval Covers All Products COPP and FSC are typically product-specific and time-bound, requiring renewal and reapplication as your export portfolio grows.
Tips for a Smoother Process
✔ Sequence your applications — IEC first, then drug-specific approvals — rather than trying to parallel-process everything at once
âś” Apply for COPP and FSC for new products well ahead of any African market registration timeline, since those documents feed directly into NAFDAC/PPB/FDA Ghana applications
âś” Keep WHO-GMP certification current across your facility, since it underlies most of the downstream approvals
âś” Maintain a master compliance file per product covering every Indian-side document, to keep information consistent when it’s reused in destination-country dossiers
Conclusion
A pharma export license India to Africa route requires isn’t a single certificate — it’s a sequence of India-side approvals (IEC, drug license, export NOC, COPP, FSC) that together make a product export-ready, before destination-country registration with NAFDAC, PPB, or FDA Ghana even begins. Exporters who treat this as a structured sequence, rather than a single application, move products to market faster and with far fewer compliance surprises.
Partnering with an experienced Pharma export company in India that has these approvals in place across a broad product portfolio removes much of this groundwork for African buyers and distributors.